Immediate Impact
10 standout
Citing Papers
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
2023 Standout
Trends in kinase drug discovery: targets, indications and inhibitor design
2021 Standout
Works of Allison Perrin being referenced
Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the US
2014
Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Allison Perrin | 18 | 15 | 3 | 36 | 35 | 12 | 82 | |
| Seungjean Chai | 11 | 4 | 1 | 55 | 23 | 13 | 115 | |
| Timothy F. Goggins | 7 | 21 | 6 | 50 | 20 | 12 | 88 | |
| Amalia Pérez‐Gil | 19 | 7 | 22 | 33 | 15 | 182 | ||
| R. Rajan | 21 | 22 | 3 | 21 | 42 | 13 | 171 | |
| Bernadette Vertogen | 13 | 24 | 1 | 107 | 78 | 13 | 175 | |
| Steffen Dörfel | 4 | 5 | 12 | 49 | 22 | 13 | 92 | |
| Raluca Popescu | 16 | 5 | 5 | 35 | 10 | 14 | 194 | |
| Pankaj Mistry | 6 | 11 | 2 | 83 | 21 | 18 | 170 | |
| Mad‐Hélénie Elsensohn | 25 | 4 | 12 | 9 | 19 | 14 | 176 | |
| Xiaoyong Qi | 18 | 8 | 3 | 9 | 16 | 15 | 177 |
All Works
Loading papers...